OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD)
Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis (2019) Vol. 11, Iss. 8, pp. 1122-1133
Open Access | Times Cited: 68
Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis (2019) Vol. 11, Iss. 8, pp. 1122-1133
Open Access | Times Cited: 68
Showing 1-25 of 68 citing articles:
New psychoactive substances: a review and updates
Abu Shafi, Alex J. Berry, Harry Sumnall, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 248
Abu Shafi, Alex J. Berry, Harry Sumnall, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 248
Designer drugs: mechanism of action and adverse effects
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 214
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 214
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein, et al.
Neuropharmacology (2020) Vol. 167, pp. 107933-107933
Open Access | Times Cited: 195
Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein, et al.
Neuropharmacology (2020) Vol. 167, pp. 107933-107933
Open Access | Times Cited: 195
The neural basis of psychedelic action
Alex C. Kwan, David E. Olson, Katrin H. Preller, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 11, pp. 1407-1419
Closed Access | Times Cited: 170
Alex C. Kwan, David E. Olson, Katrin H. Preller, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 11, pp. 1407-1419
Closed Access | Times Cited: 170
Chemistry and Structure–Activity Relationships of Psychedelics
David E. Nichols
Current topics in behavioral neurosciences (2017), pp. 1-43
Closed Access | Times Cited: 95
David E. Nichols
Current topics in behavioral neurosciences (2017), pp. 1-43
Closed Access | Times Cited: 95
Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens
Adam L. Halberstadt
Current topics in behavioral neurosciences (2017), pp. 283-311
Open Access | Times Cited: 92
Adam L. Halberstadt
Current topics in behavioral neurosciences (2017), pp. 283-311
Open Access | Times Cited: 92
Chronic pain and psychedelics: a review and proposed mechanism of action
Joel Castellanos, C. Leonard Woolley, Kelly Bruno, et al.
Regional Anesthesia & Pain Medicine (2020) Vol. 45, Iss. 7, pp. 486-494
Closed Access | Times Cited: 91
Joel Castellanos, C. Leonard Woolley, Kelly Bruno, et al.
Regional Anesthesia & Pain Medicine (2020) Vol. 45, Iss. 7, pp. 486-494
Closed Access | Times Cited: 91
Effect of Hallucinogens on Unconditioned Behavior
Adam L. Halberstadt, Mark A. Geyer
Current topics in behavioral neurosciences (2016), pp. 159-199
Open Access | Times Cited: 82
Adam L. Halberstadt, Mark A. Geyer
Current topics in behavioral neurosciences (2016), pp. 159-199
Open Access | Times Cited: 82
Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications
Orr Shahar, Alexander Botvinnik, Noam Esh-Zuntz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14148-14148
Open Access | Times Cited: 33
Orr Shahar, Alexander Botvinnik, Noam Esh-Zuntz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14148-14148
Open Access | Times Cited: 33
Application of Quantum–Chemical Methods in the Forensic Prediction of Psychedelic Drugs’ Spectra (IR, NMR, UV–VIS, and MS): A Case Study of LSD and Its Analogs
Jelica Džodić, Dejan Milenković, Milica Marković, et al.
Applied Sciences (2023) Vol. 13, Iss. 5, pp. 2984-2984
Open Access | Times Cited: 21
Jelica Džodić, Dejan Milenković, Milica Marković, et al.
Applied Sciences (2023) Vol. 13, Iss. 5, pp. 2984-2984
Open Access | Times Cited: 21
Return of the lysergamides. Part II: Analytical and behavioural characterization of N6‐allyl‐6‐norlysergic acid diethylamide (AL‐LAD) and (2’S,4’S)‐lysergic acid 2,4‐dimethylazetidide (LSZ)
Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis (2016) Vol. 9, Iss. 1, pp. 38-50
Open Access | Times Cited: 59
Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis (2016) Vol. 9, Iss. 1, pp. 38-50
Open Access | Times Cited: 59
In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures
Lea Wagmann, Lilian H.J. Richter, Tobias Kehl, et al.
Analytical and Bioanalytical Chemistry (2019) Vol. 411, Iss. 19, pp. 4751-4763
Open Access | Times Cited: 50
Lea Wagmann, Lilian H.J. Richter, Tobias Kehl, et al.
Analytical and Bioanalytical Chemistry (2019) Vol. 411, Iss. 19, pp. 4751-4763
Open Access | Times Cited: 50
NPS: Medical Consequences Associated with Their Intake
Fabrizio Schifano, Laura Orsolini, Duccio Papanti, et al.
Current topics in behavioral neurosciences (2016), pp. 351-380
Open Access | Times Cited: 48
Fabrizio Schifano, Laura Orsolini, Duccio Papanti, et al.
Current topics in behavioral neurosciences (2016), pp. 351-380
Open Access | Times Cited: 48
How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings—A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae
Lea Wagmann, Fabian Frankenfeld, Yu Mi Park, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 44
Lea Wagmann, Fabian Frankenfeld, Yu Mi Park, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 44
Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products
Rie Tanaka, Maiko Kawamura, Sakumi Mizutani, et al.
Forensic Toxicology (2023) Vol. 41, Iss. 2, pp. 294-303
Open Access | Times Cited: 15
Rie Tanaka, Maiko Kawamura, Sakumi Mizutani, et al.
Forensic Toxicology (2023) Vol. 41, Iss. 2, pp. 294-303
Open Access | Times Cited: 15
Stimulant and hallucinogenic novel psychoactive substances; an update
Fabrizio Schifano, Alessandro Vento, Norbert Scherbaum, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1109-1123
Open Access | Times Cited: 14
Fabrizio Schifano, Alessandro Vento, Norbert Scherbaum, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1109-1123
Open Access | Times Cited: 14
Analytical and behavioral characterization of 1‐dodecanoyl‐LSD (1DD‐LSD)
Pierce V. Kavanagh, Folker Westphal, Benedikt Pulver, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 6
Pierce V. Kavanagh, Folker Westphal, Benedikt Pulver, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 6
Synthesis and analytical characterization of 1‐(2‐thienoyl)‐6‐allyl‐nor‐d‐lysergic acid diethylamide (1T‐AL‐LAD)
Y Okada, Hiroki Segawa, Tadashi Yamamuro, et al.
Drug Testing and Analysis (2024)
Closed Access | Times Cited: 5
Y Okada, Hiroki Segawa, Tadashi Yamamuro, et al.
Drug Testing and Analysis (2024)
Closed Access | Times Cited: 5
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)
Simon D. Brandt, Pierce V. Kavanagh, Brendan Twamley, et al.
Drug Testing and Analysis (2017) Vol. 10, Iss. 2, pp. 310-322
Open Access | Times Cited: 47
Simon D. Brandt, Pierce V. Kavanagh, Brendan Twamley, et al.
Drug Testing and Analysis (2017) Vol. 10, Iss. 2, pp. 310-322
Open Access | Times Cited: 47
An overview of emerging and new psychoactive substances in the United Kingdom
Shruti Beharry, Simon Gibbons
Forensic Science International (2016) Vol. 267, pp. 25-34
Open Access | Times Cited: 43
Shruti Beharry, Simon Gibbons
Forensic Science International (2016) Vol. 267, pp. 25-34
Open Access | Times Cited: 43
Return of the lysergamides. Part III: Analytical characterization of N6‐ethyl‐6‐norlysergic acid diethylamide (ETH‐LAD) and 1‐propionyl ETH‐LAD (1P–ETH‐LAD)
Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis (2017) Vol. 9, Iss. 10, pp. 1641-1649
Open Access | Times Cited: 42
Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis (2017) Vol. 9, Iss. 10, pp. 1641-1649
Open Access | Times Cited: 42
Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics
James Sexton, Charles D. Nichols, Peter S. Hendricks
Frontiers in Psychiatry (2020) Vol. 10
Open Access | Times Cited: 38
James Sexton, Charles D. Nichols, Peter S. Hendricks
Frontiers in Psychiatry (2020) Vol. 10
Open Access | Times Cited: 38
Automated detection of the head-twitch response using wavelet scalograms and a deep convolutional neural network
Adam L. Halberstadt
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Adam L. Halberstadt
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 37
New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions
Chinaza Godswill Awuchi, Patrick Maduabuchi Aja, Nancy Bonareri Mitaki, et al.
Journal of Chemistry (2023) Vol. 2023, pp. 1-36
Open Access | Times Cited: 13
Chinaza Godswill Awuchi, Patrick Maduabuchi Aja, Nancy Bonareri Mitaki, et al.
Journal of Chemistry (2023) Vol. 2023, pp. 1-36
Open Access | Times Cited: 13
